Ā | Large volume preparation (nĀ =ā9) | Medium volume preparation (nĀ =ā8) | Low volume preparation (nĀ =ā8) | Total (nĀ =ā25) | P-value |
---|---|---|---|---|---|
Female gender, n (%) | 3 (33.3%) | 3 (37.5%) | 2 (25.0%) | 8 (32.0%) | 0.86 |
Age (years) | |||||
āMean (Ā±SD) | 70.8 (Ā±12.33) | 62.1 (Ā±17.46) | 66.5(Ā±19.79) | 66.6 (Ā±16.34) | 0.57 |
āRange | 51ā86 | 32ā85 | 35ā84 | 32ā86 | |
BMI (kg/m2) | |||||
āMean (Ā±SD) | 29.1 (Ā±4.21) | 25.3 (Ā±3.67) | 29.8 (Ā±7.59) | 28.2 (Ā±5.57) | 0.25 |
āRange | 22.9ā35.7 | 18.2ā29.8 | 23.2ā45.6 | 18.2ā45.6 | |
Diabetes, n (%) | 2 (22.2) | 2 (28.6) | 2 (25.0) | 6 (25.0) | 0.96 |
Chronic constipation, n (%) | 1 (11.1) | 1 (14.3) | 2 (25.0) | 4 (16.7) | 0.73 |
Neurologic disease, n (%) | 0 | Lewy body dementia: 1 (12.5) | Paraplegia: 1 (12.5) | 2 (8) | 0.36 |
Use of medication that may cause constipation | Opiate: 2 (22.2) | Opiate: 1 (12.5) Opiate + Carbidopa: 1 (12.5) | Opiate: 2 (25) Nortryptiline: 1 (12.5) | Opiate: 5 (20) Opiate + carbidopa: 1 (4) Nortryptiline: 1 (4) | 0.58 |
Indication for colonoscopy | |||||
āAbnormal imaging | 0 (0.0%) | 1 (12.5%) | 0 (0.0%) | 1 (4.0%) | 0.71 |
āDiarrhea | 1 (11.1%) | 2 (25.0%) | 2 (25.0%) | 5 (20.0%) | |
āHematochezia | 6 (66.7%) | 3 (37.5%) | 3 (37.5%) | 12 (48.0%) | |
āIBD | 0 (0.0%) | 0 (0.0%) | 1 (12.5%) | 1 (4.0%) | |
āMelena | 1 (11.1%) | 0 (0.0)% | 1 (12.5%) | 2 (8.0%) | |
āAbdominal pain | 0 (0.0%) | 1 (12.5%) | 0 (0.0%) | 1 (4.0%) | |
āAnemia | 1 (11.1%) | 1 (12.5%) | 1 (12.5%) | 3 (12.0%) |